This was not surprising as GCKR was previously shown to enhance hepatic glucose uptake resulting in reduced fatty acid oxidation and increased hepatic de novo lipogenesis [59] augmenting both the risk of NAFLD and metabolic aberrations [6]. Here, GCKR is linked to metabolic dysfunction-associated steatotic liver disease.